Drug Infusion Systems Market Size to Reach Valuation of USD 18.17 Billion in 2028

September 14, 2022 |

13 min read

The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research.

The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research. The growing adoption of technologically advanced pump systems and the rising prevalence of chronic diseases are projected to drive the market growth over the forecast period.

Drug infusion pumps are devices that help in the delivery of medication, by infusing small doses of drugs, into the patient’s body, at a pre-programmed rate. These pumps are majorly used for intravenous delivery of drugs and are also known as IV pumps. Drug infusion systems are classified into two types, namely, large volume pumps and syringe pumps. Large volume pumps are used to deliver a large volume of fluids, whereas syringe pumps are used for the delivery of small volumes of fluids.

Increasing demand for safe and precise drug delivery systems , along with the rising prevalence of chronic diseases, is projected to drive the market growth. According to the World Health Organization (WHO), in 2017, around 362 million people were suffering from diabetes worldwide, and this number is expected to rise to 592 million by 2035. Furthermore, according to the National Kidney Foundation, in 2019, around 30 million people were suffering from chronic kidney diseases in the U.S., and this number is expected to grow to over 50% by 2030. Thus, the rising prevalence of chronic diseases is projected to propel the demand for drug infusion systems during the forecast period.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/692

In addition, the increasing adoption of technologically advanced pump systems is another factor projected to drive the market growth. For instance, in October 2019, Becton Dickinson & Company launched BD IntelliTec X2 pump system, which is a next-generation ambulatory infusion platform that helps in enhancing patient safety and clinical workflow.

However, the high cost of drug infusion systems and lack of skilled professionals are projected to restraint the market growth during the forecast period.

Some Key Highlights from the Report

Key players in the market include Medtronic plc, Arcomed Ag, Baxter International Inc., Insulet Corporation, Smiths Group plc, Becton, Dickinson and Company, Halyard Health, Inc., ICU Medical, Inc., Flowonix Medical Inc., and Zyno Medical LLC.
In February 2020, Abbott Laboratories announced a partnership with Insulet Corporation to develop a new, integrated glucose monitoring system for people with diabetes who use insulin pumps. The new system will be designed to automatically and continuously measure glucose levels in interstitial fluid, and provide real-time alerts to users if their glucose levels are getting too high or low.
In December 2019, Dexcom, Inc., acquired TypeZero Technologies, Inc., a digital health company that has developed an artificial pancreas technology platform for the management of diabetes. The acquisition will allow Dexcom to enter the insulin pump market and expand its product portfolio with new capabilities for people with diabetes.
In May 2019, F. Hoffmann-La Roche Ltd acquired mySugr GmbH, a digital health company that provides solutions for people with diabetes. The acquisition will allow Roche to expand its product portfolio with new capabilities for people with diabetes.
The open-loop system segment revenue is expected to expand at a significant CAGR during the forecast period due to the rising adoption of these systems in ambulatory surgeries and home healthcare. Ambulatory surgery centers (ASCs) are preferred for less complex surgeries that do not require hospitalization, as they are cost-effective as compared to hospitals. Open-loop systems are used during ambulatory surgeries as they provide precision and control over the drug delivery process. However, the government initiatives to promote home healthcare and the rising preference for home-based treatment are expected to drive the growth of the closed-loop system segment during the forecast period.
The syringe pumps segment is estimated to account for a major market share in 2020, due to their widespread use in various applications such as ambulatory surgery, cancer treatment, and pain management. The cancer treatment segment is expected to grow at a rapid pace during the review period due to the rise in the number of cancer cases globally. According to the International Agency for Research on Cancer (IARC), approximately 14.1 million new cancer cases were reported in 2012, which increased to 18.1 million in 2018.
Hospitals segment accounted for the largest market share in 2020 and is expected to grow at a rapid pace during the forecast period. The growth of this end-user segment can be attributed to the increase in the number of hospitals and ambulatory surgery centers (ASCs) and the rise in the number of surgeries being performed globally. According to the World Health Organization (WHO), there were approximately 37 million hospital admissions globally in 2016.
North America accounted for the largest market share in 2020 due to the favorable reimbursement policies, increase in the number of surgeries, and rise in healthcare expenditure. For instance, according to the Centers for Medicare & Medicaid Services (CMS), total health expenditure was USD 3.3 trillion in 2015, which increased to USD 3.5 trillion in 2016 in the U.S.
Asia-Pacific is expected to be the fastest-growing region due to the favorable reimbursement policies, increase in healthcare expenditure, and growth of the medical tourism industry in countries such as India and China. The government initiatives to promote home healthcare and the rising preference for home-based treatment are expected to drive the growth of this region during the forecast period.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/drug-infusion-systems-market

Emergen Research has segmented the global drug infusion systems market on the basis of control systems, infusion type, administration route, application, end-use, and region:

Control Systems Outlook (Revenue, USD Billion; 2018–2028)

Open Loop System
Closed Loop System

Infusion Type Outlook (Revenue, USD Billion; 2018–2028)

Continuous Infusion
Intermittent Infusion
Patient Controlled Infusion
Total Parenteral Nutrition

Administration Route Outlook (Revenue, USD Billion; 2018–2028)

Enteral
Subcutaneous
Intravenous
Arterial
Epidural

Application Outlook (Revenue, USD Billion; 2018–2028)

Pediatrics
Diabetes
Nutrition
Hematology
Analgesia
Chemotherapy
Others

End-Use Outlook (Revenue, USD Billion; 2018–2028)

Diagnostic Centers
Hospitals
Ambulatory Surgical Centers
Others

Regional Outlook (Revenue, USD Billion; 2018–2028)

North America
1. U.S.
2. Canada
3. Mexico
Europe
1. Germany
2. France
3. U.K.
4. Italy
5. Spain
6. BENELUX
7. Rest of Europe
Asia Pacific
1. China
2. India
3. Japan
4. South Korea
5. Rest of APAC
Latin America
1. Brazil
2. Rest of LATAM
Middle East & Africa
1. Saudi Arabia
2. UAE
3. South Africa
4. Turkey
5. Rest of MEA

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/692

Explore More Reports Emergen Research:

Smart Building Market

Photolithography equipment market

Animal Ultrasound Market

Aviation Fuel Systems Market

Optically Clear Adhesive Market

Small Caliber Ammunition Market

Metaverse market

Smart irrigation market

Ceramic fiber market

Acrylic resin market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee

Corporate Sales Specialist

14671 110 Avenue, Surrey, British Columbia, V3R2A9

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Emergen Research Media Citations: https://www.emergenresearch.com/media-citations

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available @ https://www.emergenresearch.com/press-release/global-drug-infusion-systems-market

Latest Published Titles Smart Cities Market | Smart Learning Market

The global hemodynamic monitoring market size is expected to reach USD 1,566.7 Million at a steady CAGR of 6.1% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cardiovascular diseases and technological advancements are expected to create significant growth opportunities for the market during the forecast period.

The market is anticipated to be driven by the rising number of geriatric population and growing awareness about early detection & management of chronic diseases. According to a report published by the United Nations in 2017, the global population aged 60 years or above is projected to reach nearly 2 billion by 2050 from 900 million in 2015. Furthermore, the World Health Organization (WHO) has estimated that the number of people suffering from cardiovascular diseases will rise to 23.6 million by 2030.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/694

Technological advancements in hemodynamic monitoring devices are expected to create significant growth opportunities for the market during the forecast period. For instance, in March 2018, Philips launched IntelliVue X3 mobile cardiac output monitor with the aim of providing clinicians with a real-time view of a patient’s hemodynamic status. This device is integrated with Philips’ advanced iFR Simplicity software that provides an easy-to-use interface for calculating Fractional Flow Reserve (FFR).

Some Key Highlights from the Report

Key players in the market include GE Healthcare, Drager Medical GmbH, Edward Lifesciences Corporation, Philips Medical, Hemo Sapiens, Inc., Deltex Medical, Lidco Group, Schwarzer Cardiotek GmbH, Tensys Medical Inc., and Koninklijke Philips NV.
These players are focused on launching new products and expanding their geographic reach to gain a competitive edge in the market. For instance, in August 2018, Getinge AB launched a new version of ARYX hemodynamic monitoring system that includes an advanced software for improved patient care.
In terms of product type, the arterial line products segment is expected to hold the largest market share in 2028. This growth can be attributed to the fact that arterial lines offer a direct and accurate measure of central hemodynamics as compared to other indirect measures. Also, arterial lines are more commonly used in critical care settings as they provide real-time data on MAP, cardiac output, and SVR.
In terms of application, the intensive care units (ICU) segment is expected to hold the largest market share in 2028. This growth can be attributed to the fact that hemodynamic monitoring is extensively used in ICU settings to guide fluid therapy and inotropes/vasopressors. Also, hemodynamic monitoring is helpful in early detection of organ dysfunction and predicting clinical outcomes in critically ill patients.
On the basis of end-use, the hospitals & clinics segment is expected to generate the largest revenue in 2028. Increasing number of surgeries and growing adoption of hemodynamic monitoring devices are anticipated to drive the demand for these devices in hospitals.
North America is expected to hold the largest market share in 2028 owing to the presence of major players in the region and rising awareness about early detection & management of chronic diseases. For instance, in October 2018, Edwards Lifesciences Corporation launched the fourth-generation HemoSphere monitoring system that provides clinicians with a real-time view of global hemodynamics. This system is integrated with an iFR Simplicity software that offers an easy-to-use interface for calculating Fractional Flow Reserve (FFR).

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/hemodynamic-monitoring-devices-market

Emergen Research has segmented the global hemodynamic monitoring devices market on the basis of product, type, end-use, and region:

Product Outlook (Revenue, USD Million; 2018–2028)